Cannabis U.S. Companies

[JohnCM]

CV Sciences

CVSI

CONTACT DETAILS

2688 South Rainbow Boulevard

Suite B

Las Vegas, NV 89146

www.cvsciences.com

[phone]

[e-mail]

DESCRIPTION

CV Sciences, Inc. is a life science company that operates through two segments, specialty pharmaceuticals and consumer products. The Company focuses on developing and commercializing proprietary prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient and is engaged in the development, manufacturing, marketing and sale of consumer products containing plant-based CBD, which is refined into its own proprietary branded products. CV Sciences initial drug candidate (CVSI-007) is a chewing gum that combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction. The market for cessation of smokeless tobacco use and addiction is estimated at $2 billion, growing to over $4 billion in the next 5-6 years.

SECURITY DETAILS

Market Cap
248,253,919
07/27/2018

Shares Out
91,945,896
06/29/2018